Caltech Heritage Project: A profile on Tom Miller, CEO of Iambic

Presentations

This is some text inside of a div block.

June 1, 2022

Media Contacts

Related announcements

Iambic Announces Enchant v2, its Next Generation AI Model for Predicting the Clinical Viability of Drug Discovery Programs

Iambic Announces Enchant v2, its Next Generation AI Model for Predicting the Clinical Viability of Drug Discovery Programs

Enchant v2: Pushing the Boundaries of Predictive Drug Discovery

Enchant v2: Pushing the Boundaries of Predictive Drug Discovery

Iambic to Participate in Upcoming Investor Conferences

Iambic to Participate in Upcoming Investor Conferences